跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
立雅 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lamotrigine Dispersible Tablets
Approved
化学药品
Lamotrigine Dispersible Tablets
Actavis Group ehf.
🇨🇳 National Medical Products Administration
Approval Date
Jun 25, 2018
Approval ID
7MaoT1I3pWu
Company
Actavis Group ehf.
Type
化学药品
Approval Details
Approval Id
7MaoT1I3pWu
Approval Number
H20110590
Generic Name
拉莫三嗪分散片
Generic Name En
Lamotrigine Dispersible Tablets
Trade Name
Lamotrin
Brand Name
立雅
Drug Type
化学药品
Dosage Form
片剂
Strength
50mg
Reg Date
2018-06-25
Expired Date
2023-06-24
Company Name
Actavis Group ehf.
Company Address
Reykjavikurvegur 76-78, 220 Hafnarfjordur,Iceland
Production Company Name
specifar s.a.
Production Company Address
1, 28 Octovriou street, Agia Varvara, 123 51, Greece
Company Detail Path
/organization/actavis-group-ehf
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 25, 2018
Approval ID
7MaoT1I3pWu
Type
化学药品
Back to NMPA Approvals